Research progress in the association of metabolic syndrome with nephrolithiasis
WU Baisuo1, GUO Junyi2, WANG Jinbo2
1 Graduate School of Xinxiang Medical College,Xinxiang 453000,China; 2 Department of Urology,No.371 Central Hospital of Chinese People's Liberation Army
Abstract：In recent years, the prevalence of the metabolic syndrome (MS) and nephrolithiasis is both increasing rapidly. More studies have showed that the MS and its components are closely related to the formation, development and recurrence of nephrolithiasis. This article reviews the current situation and progress of the research on the correlation between the MS and its components and nephrolithiasis, and provides some help for the clinical treatment of nephrolithiasis in patients with MS.
武佰锁, 郭君毅, 王锦波. 代谢综合征与肾结石的相关性研究进展[J]. 微创泌尿外科杂志, 2019, 8(4): 280-286.
WU Baisuo, GUO Junyi, WANG Jinbo. Research progress in the association of metabolic syndrome with nephrolithiasis. JOURNAL OF MINIMALLY INVASIVE UROLOGY, 2019, 8(4): 280-286.
[1] LIU YT, YANG PY, YANG YW, et al.The association of nephrolithiasis with metabolic syndrome and its components: a cross-sectional analysis. Ther Clin Risk Manag, 2017,13:41-48. [2] HOFFMAN EL, VONWALD T, HANSEN K.The metabolic syndrome. S D Med, 2015:24-28. [3] ALBERTI KG, ECKEL RH, GRUNDY SM, et al.Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; NationalHeart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 2009,120(16):1640-1645. [4] RAMPAL S, MAHADEVA S, GUALLAR E, et al.Ethnic differences in the prevalence of metabolic syndrome: results from a Multi-Ethnic Population-Based survey in Malaysia. PLoS One, 2012,7(9):e46365. [5] MOHAMUD WN, ISMAIL AA, SHARIFUDDIN A, et al.Prevalence of metabolic syndrome and its risk factors in adult Malaysians: Results of a nationwide survey. Diabetes Res Clin Pract, 2011,91(2):239-245. [6] YEH CJ, CHANG HY, PAN WH.Time trend of obesity, the metabolic syndrome and related dietary pattern in Taiwan: from NAHSIT 1993-1996 to NAHSIT 2005-2008. Asia Pac J Clin Nutr, 2011,20(2):292-300. [7] ZENG G, MAI Z, XIA S, et al.Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int, 2017,120(1):109-116. [8] LIU M, WANG J, JIANG B, et al.Increasing prevalence of metabolic syndrome in a Chinese elderly population: 2001-2010. PLoS One, 2013,8(6):e66233. [9] ROMERO V, AKPINAR H, ASSIMOS DG.Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol, 2010,12(2/3): e86-e96. [10] RAMELLO A, VITALE C, MARANGELLA M.Epidemiology of nephrolithiasis. J Nephrol, 2000,13(Suppl 3):S45-S50. [11] SCALES J, SMITH AC, HANLEY JM, et al.Prevalence of kidney stones in the United States. Eur Urol, 2012,62(1):160-165. [12] AGUILAR M, BHUKET T, TORRES S, et al.Prevalence of the metabolic syndrome in the United States. JAMA, 2015,313(19):1973-1974. [13] SAKHAEE K.Recent advances in the pathophysiology of nephrolithiasis. Kidney Int, 2009,75(6):585-595. [14] OBLIGADO SH, GOLDFARB DS.The association of nephrolithiasis with hypertension and obesity: A review. Am J Hypertens, 2008,21(3):257-264. [15] LANGE JN, MUFARRIJ PW, WOOD KD, et al.The association of cardiovascular disease and metabolic syndrome with nephrolithiasis. Curr Opin Urol, 2012,22(2):154-159. [16] REINER AP, KAHN A, EISNER BH, et al.Kidney stones and subclinical atherosclerosis in young adults: the CARDIA study. J Urol, 2011,185(3):920-925. [17] SAKHAEE K, CAPOLONGO G, MAALOUF NM, et al.Metabolic syndrome and the risk of calcium stones. Nephrol Dial Transplant, 2012,27(8):3201-3209. [18] DING Q, OUYANG J, FAN B, et al.Association between Dyslipidemia and Nephrolithiasis Risk in a Chinese Population. Urol Int, 2019:1-10. [19] KHAN SR.Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol Res, 2012,40(2):95-112. [20] TAYLOR EN, STAMPFER MJ, CURHAN GC.Obesity, weight gain, and the risk of kidney stones. JAMA, 2005,293(4):455-462. [21] CARBONE A, AL SALHI Y, TASCA A, et al.Obesity and kidney stone disease: a systematic review. Minerva Urol Nefrol, 2018,70(4):393-400. [22] SEMINS MJ, SHORE AD, MAKARY MA, et al.The association of increasing body mass index and kidney stone disease. J Urol, 2010,183(2):571-575. [23] MAALOUF NM, SAKHAEE K, PARKS JH, et al.Association of urinary pH with body weight in nephrolithiasis. Kidney Int, 2004,65(4):1422-1425. [24] EKERUO WO, TAN YH, YOUNG MD, et al.Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol, 2004,172(1):159-163. [25] SIENER R, GLATZ S, NICOLAY C, et al.The role of overweight and obesity in calcium oxalate stone formation. Obes Res, 2004,12(1):106-113. [26] NOUVENNE A, TICINESI A, ALLEGRI F, et al.Twenty-five years of idiopathic calcium nephrolithiasis: has anything changed? Clin Chem Lab Med, 2014,52(3):337-344. [27] NEGRI AL, SPIVACOW FR, DEL VALLE EE, et al.Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers. Urol Res, 2008,36(6):303-307. [28] WONG YV, COOK P, SOMANI BK.The association of metabolic syndrome and urolithiasis. Int J Endocrinol, 2015:570674. [29] NOWICKI M, KOKOT F, SURDACKI A.The influence of hyperinsulinaemia on calcium-phosphate metabolism in renal failure. Nephrol Dial Transplant, 1998,13(10):2566-2571. [30] TAYLOR EN, CURHAN GC.Body size and 24-hour urine composition. Am J Kidney Dis, 2006,48(6):905-915. [31] DAUDON M, LACOUR B, JUNGERS P.Influence of body size on urinary stone composition in men and women. Urol Res, 2006,34(3):193-199. [32] ABATE N, CHANDALIA M, CABO-CHAN AV, et al.The metabolic syndrome and uric acid nephrolithiasis: Novel features of renal manifestation of insulin resistance. Kidney Int, 2004,65(2):386-392. [33] PAK CY, SAKHAEE K, PETERSON RD, et al.Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int, 2001,60(2):757-761. [34] LEE SC, KIM YJ, KIM TH, et al.Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence. J Urol, 2008,179(2):570-574. [35] TIBBLIN G.A population study of 50-year-old men. An analysis of the non-participation group. Acta Med Scand, 1965,178(4):453-459. [36] TANG J, METTLER P, MCFANN K, et al.The association of prevalent kidney stone disease with mortality in US adults: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Nephrol, 2013,37(5):501-506. [37] DOMINGOS F, SERRA A.Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant, 2011,26(3):864-868. [38] KITTANAMONGKOLCHAI W, MARA KC, MEHTA RA, et al.Risk of hypertension among first-time symptomatic kidney stone formers. Clin J Am Soc Nephrol, 2017,12(3):476-482. [39] KOHJIMOTO Y, SASAKI Y, IGUCHI M, et al.Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. Am J Kidney Dis, 2013,61(6):923-929. [40] BORGHI L, MESCHI T, GUERRA A, et al.Essential arterial hypertension and stone disease. Kidney Int, 1999,55(6):2397-2406. [41] EISNER BH, PORTEN SP, BECHIS SK, et al.Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis. J Urol, 2010,183(2):576-579. [42] HARTMAN C, FRIEDLANDER JI, MOREIRA DM, et al.Does hypertension impact 24-hour urine parameters in patients with nephrolithiasis? Urology, 2015,85(3):539-543. [43] LOSITO A, NUNZI EG, COVARELLI CA, et al.Increased acid excretion in kidney stone formers with essential hypertension. Nephrol Dial Transplant, 2009,24(1):137-141. [44] KIM YJ, PARK MS, KIM WT, et al.Hypertension influences recurrent stone formation in nonobese stone formers. Urology, 2011,77(5):1059-1063. [45] CHUNG SD, CHEN YK, LIN HC.Increased risk of diabetes in patients with urinary calculi: a 5-year followup study. J Urol, 2011,186(5):1888-1893. [46] TAYLOR EN, STAMPFER MJ, CURHAN GC.Diabetes mellitus and the risk of nephrolithiasis. Kidney Int, 2005,68(3):1230-1235. [47] WEINBERG AE, PATEL CJ, CHERTOW GM, et al.Diabetic severity and risk of kidney stone disease. Eur Urol, 2014,65(1):242-247. [48] NAGASAKA S, MURAKAMI T, UCHIKAWA T, et al.Effect of glycemic control on calcium and phosphorus handling and parathyroid-hormone level in patients with non-insulin-dependent diabetes-mellitus. Endocr J, 1995,42(3):377-383. [49] EISNER BH, PORTEN SP, BECHIS SK, et al.Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol, 2010,183(6):2244-2248. [50] LANGE JN, WOOD KD, KNIGHT J, et al.Glyoxal formation and its role in endogenous oxalate synthesis. Adv Urol, 2012,2012:819202. [51] DAUDON M, TRAXER O, CONORT P, et al.Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol, 2006,17(7):2026-2033. [52] FRAM EB, MOAZAMI S, STERN JM.The effect of disease severity on 24-hour urine parameters in kidney stone patients with type 2 diabetes. Urology, 2016,87:52-59. [53] ZIMMERER T, WEISS C, HAMMES HP, et al.Evaluation of urolithiasis: a link between stone formation and diabetes mellitus? Urol Int, 2009,82(3):350-355. [54] HARTMAN C, FRIEDLANDER JI, MOREIRA DM, et al.Differences in 24-hour urine composition between nephrolithiasis patients with and without diabetes mellitus. BJU Int, 2015,115(4):619-624. [55] TORRICELLI FC, DE S, GEBRESELASSIE S, et al.Type-2 diabetes and kidney stones: impact of diabetes medications and glycemic control. Urology, 2014,84(3):544-548. [56] DOMINGOS F, SERRA A.Metabolic syndrome: A multifaceted risk factor for kidney stones. Scand J Urol, 2014,48(5):414-419. [57] SHAVIT L, FERRARO PM, JOHRI N, et al.Effect of being overweight on urinary metabolic risk factors for kidney stone formation. Nephrol Dia Transplant, 2015,30(4):607-613. [58] MAALOUF NM.Metabolic syndrome and the genesis of uric acid stones. J Ren Nutr, 2011,21(1):128-131. [59] SHIMAMOTO K, HIGASHIURA K, NAKAGAWA M, et al.Effects of hyperinsulinemia under the euglycemic condition on calcium and phosphate metabolism in non-obese normotensive subjects. Tohoku J Exp Med, 1995,177(4):271-278. [60] GRUNDY SM, CLEEMAN JI, DANIELS SR, et al.Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 2005,112(17):2735-2752. [61] INCI M, DEMIRTAS A, SARLI B, et al.Association between body mass index, lipid profiles, and types of urinary stones. Ren Fail, 2012,34(9):1140-1143. [62] CHO ST, JUNG SI, MYUNG SC, et al.Correlation of metabolic syndrome with urinary stone composition. Int J Urol, 2013,20(2):208-213. [63] KANG HW, LEE SK, KIM WT, et al.Hypertriglyceridemia and low high-density lipoprotein cholesterolemia are associated with increased hazard for urolithiasis. J Endourol, 2014,28(8):1001-1005. [64] TORRICELLI FC, DE SK, GEBRESELASSIE S, et al.Dyslipidemia and kidney stone risk. J Urol, 2014,191(3):667-672. [65] SAKHAEE K, ADAMS-HUET B, MOE OW, et al.Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int, 2002,62(3):971-979. [66] MASTERSON JH, WOO JR, CHANG DC, et al.Dyslipidemia is associated with an increased risk of nephrolithiasis. Urolithiasis, 2015,43(1):49-53. [67] ITOH Y, YOSHIMURA M, NIIMI K, et al.The role of long-term loading of cholesterol in renal crystal formation. Arch Ital Urol Androl, 2011,83(1):23-25. [68] STOLLER ML, MENG MV, ABRAHAMS HM, et al.The primary stone event: A new hypothesis involving a vascular etiology. J Urol, 2004,171(5):1920-1924. [69] KUROGI K, SUGIYAMA S, SAKAMOTO K, et al.Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: The COMPACT-CAD study. J Cardiol, 2013,62(1/2):87-94. [70] SUR RL, MASTERSON JH, PALAZZI KL, et al.Impact of statins on nephrolithiasis in hyperlipidemic patients: a 10-year review of an equal access health care system. Clin Nephrol, 2013,79(5):351-355.
